These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9059275)
1. Primary localised amyloidosis of the orbit. Murdoch IE; Sullivan TJ; Moseley I; Hawkins PN; Pepys MB; Tan SY; Garner A; Wright JE Br J Ophthalmol; 1996 Dec; 80(12):1083-6. PubMed ID: 9059275 [TBL] [Abstract][Full Text] [Related]
2. Orbital and peri-orbital amyloidosis: a report of four cases. Medel Jiménez R; Sánchez España JC; Vasquez LM; Tapia Bahamondes A; Rondón M; Francesc T; Barroso EA Orbit; 2019 Apr; 38(2):148-153. PubMed ID: 29565698 [TBL] [Abstract][Full Text] [Related]
3. Anterior orbit and adnexal amyloidosis. Al Hussain H; Edward DP Middle East Afr J Ophthalmol; 2013; 20(3):193-7. PubMed ID: 24014979 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. Hawkins PN; Lavender JP; Pepys MB N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176 [TBL] [Abstract][Full Text] [Related]
6. Primary localized orbital amyloidosis. Levine MR; Buckman G Ann Ophthalmol; 1986 May; 18(5):165-7. PubMed ID: 3717836 [TBL] [Abstract][Full Text] [Related]
7. [Localized or systemic amyloidosis? Value and limitations of Iodine-123 labelled amyloid P component scintigraphy, role of biopsy of minor salivary glands]. Hachulla E; Wechsler B; Deveaux M; Godeau P; Hatron PY; Devulder B; Janin A; Marchandise X Rev Med Interne; 1994 Mar; 15(3):182-5. PubMed ID: 8059132 [TBL] [Abstract][Full Text] [Related]
8. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172 [TBL] [Abstract][Full Text] [Related]
9. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719 [TBL] [Abstract][Full Text] [Related]
10. Ocular amyloid: adnexal and systemic involvement. Kang S; Dehabadi MH; Rose GE; Verity DH; Amin S; Das-Bhaumik R Orbit; 2020 Feb; 39(1):13-17. PubMed ID: 31577164 [No Abstract] [Full Text] [Related]
12. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract. Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609 [TBL] [Abstract][Full Text] [Related]
13. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis. Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269 [TBL] [Abstract][Full Text] [Related]
14. [Proptosis and orbital tumor in an 80-year old woman. Primary orbital amyloidosis]. Martínez del Valle F; Selva O'Callaghan A; Solans Laque R; Mijares Boeckh-Behrens T; García-Arumí J; Solé Arqués M; Bosch Gil JA; Vilardell Tarrés M Rev Clin Esp; 2001 Feb; 201(2):95-6. PubMed ID: 11345615 [No Abstract] [Full Text] [Related]
15. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis]. Maulin L; Hachulla E; Facon T; Deveaux M; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Marchandise W Rev Med Interne; 1993; 14(10):962. PubMed ID: 8009058 [TBL] [Abstract][Full Text] [Related]
16. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Gean-Marton AD; Kirsch CF; Vezina LG; Weber AL Radiology; 1991 Nov; 181(2):521-5. PubMed ID: 1924798 [TBL] [Abstract][Full Text] [Related]
17. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis. Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591 [TBL] [Abstract][Full Text] [Related]
18. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Leibovitch I; Selva D; Goldberg RA; Sullivan TJ; Saeed P; Davis G; McCann JD; McNab A; Rootman J Ophthalmology; 2006 Sep; 113(9):1657-64. PubMed ID: 16828514 [TBL] [Abstract][Full Text] [Related]
19. Primary localized orbital amyloidosis: a case report. Di Bari R; Guerriero S; Giancipoli G; Cantatore A; Sborgia G; Piscitelli D Eur J Ophthalmol; 2006; 16(6):895-7. PubMed ID: 17191204 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis. Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]